Vest Financial LLC Buys 35,771 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Vest Financial LLC boosted its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 31.0% in the third quarter, HoldingsChannel reports. The institutional investor owned 151,217 shares of the medical instruments supplier’s stock after purchasing an additional 35,771 shares during the quarter. Vest Financial LLC’s holdings in West Pharmaceutical Services were worth $45,389,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Fidelis Capital Partners LLC purchased a new position in West Pharmaceutical Services in the first quarter worth about $27,000. Crewe Advisors LLC boosted its position in shares of West Pharmaceutical Services by 322.7% during the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 71 shares during the period. Northwest Investment Counselors LLC purchased a new position in shares of West Pharmaceutical Services during the first quarter valued at approximately $40,000. Hazlett Burt & Watson Inc. purchased a new position in shares of West Pharmaceutical Services during the first quarter valued at approximately $40,000. Finally, ORG Partners LLC boosted its position in shares of West Pharmaceutical Services by 820.0% during the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier’s stock valued at $55,000 after buying an additional 123 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Trading Up 1.6 %

Shares of NYSE WST traded up $4.66 during trading hours on Friday, reaching $293.32. The stock had a trading volume of 640,174 shares, compared to its average volume of 594,825. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The firm has a market cap of $21.28 billion, a price-to-earnings ratio of 41.72, a P/E/G ratio of 10.46 and a beta of 1.01. The business’s fifty day moving average price is $299.96 and its two-hundred day moving average price is $324.95. West Pharmaceutical Services, Inc. has a 52-week low of $265.00 and a 52-week high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). The firm had revenue of $702.10 million during the quarter, compared to analysts’ expectations of $729.36 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm’s revenue for the quarter was down 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.11 EPS. Analysts expect that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

Insiders Place Their Bets

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the sale, the vice president now owns 1,478 shares in the company, valued at $443,400. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.